ABBV241115C265000
- 0.00
- 0.000.00%
AbbVie Newsroom
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205
AbbVie Options Spot-On: On November 14th, 141.69K Contracts Were Traded, With 422.71K Open Interest
AbbVie Shares Trade in the Red for Seventh Straight Session
AbbVie Initiated With an Outperform at Wolfe Research
Thursday Market Chills From Election Celebration | Live Stock
AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations
Continuity Biosciences Se Lance Dans La Mise En Œuvre De Thérapies Innovantes Grâce À Des Technologies De Diffusion Novatrices
Deutsche Bank Adjusts Price Target on AbbVie to $177 From $180, Keeps Hold Rating
Continuity Biosciences Betritt Den Markt, Um Bahnbrechende Behandlungen Mit Innovativen Darreichungstechnologien Zu Ermöglichen
Bitcoin Gets Closer to $100k Than Ever | Wall Street Today
Smart Money Is Betting Big In ABBV Options
Bitcoin Breaks Above $90k, Market Flat Wednesday | Live Stock
AbbVie Is Maintained at Overweight by JP Morgan
Today's Analyst Rating | NVIDIA Price Target Raised to $170 by Citi, Home Depot Price Target Raised to $450 by BofA Securities
J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $200
JPMorgan Trims AbbVie Target, Removes From Analyst Focus List
Express News | Abbvie : JP Morgan Cuts Target Price to $200 From $210
AbbVie Hold Rating Maintained Amid Emraclidine Trial Challenges and Competitive Pressure